Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing organ transplantation, growing cases of infectious diseases, and hurdles in approval of biosimilars.
The immunology market is segmented as below:
By Type
- Immunosuppressants
- Immuno boosters
By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the immunology market covers the following areas:
- Immunology market sizing
- Immunology market forecast
- Immunology market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
The following companies are recognized as the key players in the global immunology market: 3SBio Inc., AbbVie Inc., Amgen Inc., ANTARES PHARMA INC., Astellas Pharma Inc., Biogen Inc., Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Horizon Therapeutics Plc, ImmuNext Inc., Incyte Corp., Johnson and Johnson Services Inc., Merck KGaA, Mitsubishi Chemical Group Corp., Novartis AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd., and UCB SA.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is significant pipeline of immunology."
According to the report, one of the major drivers for this market is the growing organ transplantation.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3SBio Inc.
- AbbVie Inc.
- Amgen Inc.
- ANTARES PHARMA INC.
- Astellas Pharma Inc.
- Biogen Inc.
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Horizon Therapeutics Plc
- ImmuNext Inc.
- Incyte Corp.
- Johnson and Johnson Services Inc.
- Merck KGaA
- Mitsubishi Chemical Group Corp.
- Novartis AG
- Pfizer Inc.
- Takeda Pharmaceutical Co. Ltd.
- UCB SA